Clinical Trials Browser

Phase 3 × Not yet recruiting × camrelizumab × Clear all

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05610332 2022-11-09

Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes

Phase 3 Not yet recruiting

Gastrointestinal

Locally Advanced Gastric Cancer